GUANGZHOU BAIYUNSHAN PHARMACEUTICAL
(HKEX: 874)

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.

18.950 -

+0.050 (+0.26%)
Range 18.700 - 18.980   (1.50%)
Open 18.840
Previous Close 18.900
Bid Price 18.890
Bid Volume ('000) 22
Ask Price 18.950
Ask Volume ('000) 16
Volume ('000) 1,955
Value 36,874,100
Remark -
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events


Top Contributors

IAmPatrick avatar
9963
Followers 661
Posts 1601
USNews avatar
348
Followers 273
Posts 1283231

Loading Chart...

Please login to view stock data and analysis